Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name：CT26-hHER2 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-S24A-TM40
HER2 gene humanized CT26 cell line
Strain Name：4T1-hFAP-Luc Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230017
FAP gene humanized 4T1 cell line
Strain Name：CT26-hPSMA (2) Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S24A-TM41
PSMA gene humanized CT26 cell line
Strain Name：EG.7 OVA-hCD38-Luc Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S40-TG01
CD38 gene humanized E.G7 cell line
Strain Name：4T1-hPSMA Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S07-TM05
PSMA gene humanized 4T1 cell line
Strain Name：E.G7 OVA-hBCMA Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S40-TM03
BCMA gene humanized E.G7 cell line
Strain Name：A20-hCD40 Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S26A-TM03
CD40 gene humanized A20 cell line
Strain Name：EMT6-hMSLN Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S22A-TM03
MSLN gene humanized EMT6 cell line
Strain Name：CT26-hFAP Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230018
FAP gene humanized CT26 cell line
Strain Name：A20-hCD22 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230006
CD22 gene humanized A20 B cell line
Please fill in the order form and we will contact you within 2 working days.
